Francois Brisebois

Stock Analyst at Oppenheimer

(0)
# 4612
Out of 5,356 analysts
99
Total ratings
28.41%
Success rate
-15.67%
Average return
36 Stocks
Name Action PT Current % Upside Ratings Updated
SNSE Sensei Biotherapeuti...
Maintains: Outperform
4 4
0.36 1011.11% 2 Mar 28, 2025
ABEO Abeona Therapeutics
Initiates Coverage On: Outperform
16
6.5 146.15% 1 Mar 5, 2025
OVID Ovid Therapeutics
Upgrades: Outperform
4
0.31 1190.32% 1 Jan 29, 2025
TARS Tarsus Pharmaceutica...
Maintains: Outperform
65 72
44.03 63.52% 7 Jan 22, 2025
MNMD Mind Medicine
Reiterates: Outperform
20 20
7.68 160.42% 4 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 28
8.09 246.11% 2 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
29 30
9.43 218.13% 8 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
143 163
42.41 284.34% 4 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
56 59
35.02 68.48% 5 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
55 55
13.97 293.7% 5 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
15 15
4.11 264.96% 2 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
6 6
4.09 46.7% 5 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
11 11
3.53 211.61% 6 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14 14
11.9 17.65% 2 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
11 15
2.4 525% 4 Jun 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
2.41 937.34% 1 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
55 65
27.75 134.23% 5 Jun 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
10 10
2.45 308.16% 2 May 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
5
0.54 825.93% 3 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
152
8.76 1635.16% 2 Aug 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
63 36
21.67 66.13% 4 Aug 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 4
3.85 3.9% 3 Apr 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 60
0.29 20589.66% 3 Apr 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
7200 5400
3.67 147038.96% 2 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
80 100
n/a n/a 1 Sep 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
9
3.56 138.76% 1 Sep 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 11
1.6 587.5% 2 Aug 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 23
n/a n/a 2 Aug 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
18
2.06 773.79% 1 Jul 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 6
n/a n/a 1 Apr 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
4.54 1001.32% 1 Oct 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
19
n/a n/a 1 Jul 31, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Mar 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3240
1.49 217349.66% 1 Feb 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
99 130
n/a n/a 3 Jan 14, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
n/a n/a 1 Nov 8, 2017